NCT02382276View on ClinicalTrials.gov

A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

January 18, 2017

Study Completion Date

January 18, 2017

Conditions
Alcohol Dependence
Interventions
DRUG

Nalmefene hydrochloride

Trial Locations (7)

Unknown

Chubu, Region

Hokkaido, Region

Kanto, Region

Kinki, Region

Kyusyu, Region

Tohoku, Region

Tyugoku, Region

Sponsors
All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY